The domain on the Duffy blood group antigen for binding Plasmodium vivax and P. knowlesi malarial parasites to erythrocytes.
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Plasmodium vivax and the related simian malarial parasite P. knowlesi use the Duffy blood group antigen as a receptor to invade human erythrocytes and region II of the parasite ligands for binding to this erythrocyte receptor. Here, we identify the peptide within the Duffy blood group antigen of human and rhesus erythrocytes to which the P. vivax and P. knowlesi ligands bind. Peptides from the NH2-terminal extracellular region of the Duffy antigen were tested for their ability to block the binding of erythrocytes to transfected Cos cells expressing on their surface region II of the Duffy-binding ligands. The binding site on the human Duffy antigen used by both the P. vivax and P. knowlesi ligands maps to a 35-amino acid region. A 34-amino acid peptide from the equivalent region of the rhesus Duffy antigen blocked the binding of P. vivax to human erythrocytes, although the P. vivax ligand expressed on Cos cells does not bind rhesus erythrocytes. The binding of the rhesus peptide, but not the rhesus erythrocyte, to the P. vivax ligand was explained by interference of carbohydrate with the binding process. Rhesus erythrocytes, treated with N-glycanase, bound specifically to P. vivax region II. Thus, the interaction of P. vivax ligand with human and rhesus erythrocytes appears to be mediated by a peptide-peptide interaction. Glycosylation of the rhesus Duffy antigen appears to block binding of the P. vivax ligand to rhesus erythrocytes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Su, X.-Z., Heatwole, V. M., Wertheimer, S. P., Guinet, F., Herrfeldt, J. A., Peterson, D. S., Ravetch, J. A., & Wellems, T. E. (1995) · Cell · doi:10.1016/0092-8674(95)90055-1 · Cited by 1,219
Smith, J. D., Chitnis, C. E., Craig, A. G., Roberts, D. J., Hudson-Taylor, D. E., Peterson, D. S., Pinches, R., Newbold, C. I., & Miller, L. H. (1995) · Cell · doi:10.1016/0092-8674(95)90056-x · Cited by 1,005 · cited 1×
“falciparum-infected erythrocytes to the endothelium (6, 9, 10).”
Self-citation
Cited by
Tuning inflammation and immunity by chemokine sequestration: decoys and more
Mantovani, A., Bonecchi, R., & Locati, M. (2006) · Nature Reviews Immunology · doi:10.1038/nri1964 · Cited by 481
“All four of the extracellular domains of DARC are involved in its interaction with chemokines, and a sulphated tyrosine residue in the first extracellular domain is essential for the interaction with erythrocyte-binding proteins from malarial parasite”
BackgroundChemokines and their role in tumor growth and metastasis
Wang, J. M., Deng, X., Gong, W., & Su, S. (1998) · Journal of Immunological Methods · doi:10.1016/s0022-1759(98)00128-8 · Cited by 308
From Malaria to Chemokine Receptor: The Emerging Physiologic Role of the Duffy Blood Group Antigen
Hadley, T. J., & Peiper, S. C. (1997) · Blood · doi:10.1182/blood.v89.9.3077 · Cited by 296
Parasite ligand–host receptor interactions during invasion of erythrocytes by Plasmodium merozoites
Gaur, D., Mayer, D. C. G., & Miller, L. H. (2004) · International Journal for Parasitology · doi:10.1016/j.ijpara.2004.10.010 · Cited by 243
Self-citationTyrosine sulfation: an increasingly recognised post-translational modification of secreted proteins
Stone, M. J., Chuang, S., Hou, X., Shoham, M., & Zhu, J. Z. (2009) · New Biotechnology · doi:10.1016/j.nbt.2009.03.011 · Cited by 169
King, C. L., Michon, P., Shakri, A. R., Marcotty, A., Stanisic, D., Zimmerman, P. A., Cole-Tobian, J. L., Mueller, I., & Chitnis, C. E. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800371105 · Cited by 168
“The receptor-binding domain of PvDBP maps to the conserved, N-terminal cysteine-rich region II (PvDBPII) (9, 10).”
BackgroundSelf-citationChoe, H., Moore, M. J., Owens, C. M., Wright, P. L., Vasilieva, N., Li, W., Singh, A. P., Shakri, R., Chitnis, C. E., & Farzan, M. (2005) · Molecular Microbiology · doi:10.1111/j.1365-2958.2004.04478.x · Cited by 148
Self-citationTournamille, C., Filipe, A., Wasniowska, K., Gane, P., Lisowska, E., Cartron, J., Colin, Y., & Le Van Kim, C. (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04533.x · Cited by 56
“…of DARC, which carries the Fya and Fy6 blood group antigens (Wasniowska et al, 2000a), is sufficient for the interaction with the P. vivax and P. knowlesi erythrocyte-binding proteins (Chitnis et al, 1996), and is responsible for the promiscuous chemokine-binding profile of DARC (Lu et al, 1995).”
Background
Metadata
- Authors
- Chitnis, C. E., Chaudhuri, A., Horuk, R., Pogo, A. O., & Miller, L. H.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1996-10-01
- Volume
- 184
- Issue
- 4
- Pages
- 1531-1536
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2119040598
- Cited by
- 182
- References
- 2
- FWCI
- 6.36
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.